Zola Therapeutics' Z-007 is a new anti-cancer immune therapy. This project developed a simple, clean visualization of its mode of action. A gradient chart was also created to compare Z-007 with competitor therapies across two modes of action: T-cell induction and cytokine activation, clearly positioning Z-007 as the optimal combination.

Project Use & Impact: The visualizations were used in investor presentations and scientific communications to demonstrate Z-007's competitive advantage, helping stakeholders quickly grasp the therapy's unique positioning in the treatment landscape.

Key challenge: Simplifying complex immunotherapy mechanisms and comparative data into clear visuals accessible to both scientific and non-scientific audiences.

Studio roles:
Illustration: Neda Ivanova
Storyboard: LifeScience Animation